Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 10, 1997, Pages 991-998

  Rainsford, K D ^a,b   Ying, C ^b   Smith, F C ^c  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c Sir William Osler Health Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; EXPLANT; HUMAN; HUMAN TISSUE; NONHUMAN; ORGAN CULTURE; OSTEOARTHRITIS; PROTEOGLYCAN SYNTHESIS; SWINE; SYNOVIUM;

EID: 0030697233     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06030.x     Document Type: Article

References (28)

1. Bayliss, M. T., Roughley, P. J. (1985) The properties of proteoglycan prepared from human articular cartilage by using associative cesium chloride gradients of high and low starting densities. Biochem. J. 232: 111-117
2. Bonta, I. L., Elliott, G. R. (1992) Non-steroidal anti-inflammatory drugs and the augmented lipoxygenase pathway: conceivable impact on joint conditions. In: Rainsford, K. D., Velo, G. P. (eds) Side Effects of Anti-inflammatory Drugs 3. Kluwer Academic Publishers, Lancaster, pp 269-274
3. Churchill, L., Graham, A. G., Shin, C.-K., Pauletti, D., Farina, P. R., Grob, P. M. (1996) Selective inhibition of human cyclooxygenase-2 by meloxicam. Inflammopharmacology 4: 125-135
4. Degner, F., Heinzel, G., Busch, U. (1994) Transsynovial kinetics of meloxicam. Scand. J. Rheumatol. 23 (Suppl 98): abstract 121
5. Dingle, J. T. (1992) NSAIDs and human cartilage metabolism. In: Rainsford, K. D., Velo, G. P. (eds) Side Effects of Anti-inflammatory Drugs 3. Kluwer Academic Publishers, Lancaster, pp 261-268
6. Distel, M., Mueller, C., Bluhmki, E. (1996) Global analysis of gastrointestinal safety of a new NSAID, meloxicam. Inflammopharmacology 4: 71-81
7. Engelhardt, G., Homma, D., Schlegel, K., Utzmann, R., Schnitzler, C. (1995) Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm. Res. 44: 423-433
8. Engelhardt, G., Bgel, R., Schnitzler, C., Utzmann, R. (1996) Meloxicam: influence on arachidonic acid metabolism. In vitro findings-Part I. Biochem. Pharmacol. 51: 21-28
9. Farndale, R. W., Savers, C. A., Barrett, A. J. (1982) A direct spectrophotometric microassay for sulphated glycosaminoglycan in articular cartilage cultures. Connect. Tissue Res. 9: 247-248
10. Graeve, L., Baumarm, M., Heinrich, P. C. (1993) Interleukin-6 in autoimmune diseases. Role of IL-6 in physiology and pathology of immune defence. Clin. Invest. 71: 664-671
11. 2 in a murine model of inflammation: possible role of cyclo-oxygenase-2. Proc. Natl Acad. Sci. USA 93: 4885-4890
12. Hopkins, S. J., Humphreys, M. (1989) Simple, sensitive and specific bioassay of interleukin-1. J. Immunol. Methods 120: 271-276
13. Hopkins, S. J., Holt, I., Humphreys, M. (1990) Removal of inhibitory activity and determination of biologically active interleukin-1 in biological fluids. In: Dinarell, C. A., Kluger, M. J., Powanda, M. C., Oppenheim, J. J. (eds) The Physiological and Pathological Effects of Cytokines. Wiley-Liss, New York, pp 7-12
14. Jones, A. C., Doherty, M. (1992) The treatment of osteoarthritis. Br. J. Clin. Pharmacol. 33: 357-363
15. Lombardino, J. G., Wiseman, E. H. (1987) Piroxicam. In: Lewis, A. J., Furst, D. E. (eds) Nonsteroidal Anti-inflammatory Drugs. Mechanisms and Clinical Use. Marcel Dekker, New York and Basel, pp 487-507
16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the folm phenol reagent. J. Biol. Chem. 193: 265-275
17. Pottenger, L. A., Webb, J. E., Lyon, N. B. (1985) Kinetics of extraction of proteoglycans from human cartilage. Arthritis Rheum. 28: 323-330
18. Rainsford, K. D. (1996) Mode of action, uses, and side effects of anti-inflammatory drugs. In: Rainsford, K. D. (ed.) Advances in Anti-Rheumatic Therapy. CRC Press, Boca Raton, pp 59-111
19. Rainsford, K. D., Davies, A., Mundy, L., Ginsburg, I. (1989) Comparative effects of azapropazone on cellular events at inflamed sites. Influence on joint pathology in arthritic rats, leucocyte superoxide and eicosanoid production, platelet aggregation, synthesis of cartilage proteoglycans, synovial production and actions of interleukin-1 in cartilage resorption correlated with drug uptake into cartilage in-vitro. J. Pharm. Pharmacol. 41: 322-330
20. Rainsford, K. D., Rashad, S. Y., Revell, P. A., Low, F. M., Hemingway, A. P., Walker, F. S., Johnson, D., Stetsko, P., Ying, C., Smith, F. (1992) Effects of NSAIDs on cartilage proteoglycan and synovial prostaglandin metabolism in relation to joint deterioration in osteoarthritis In: Blint, G., Gmr, L., Hodinka, L. (eds) Rheumatology, State of the Art, Elsevier, Amsterdam, pp 177-183
21. Rainsford, K. D., Ying, C., Smith, F. (1996) Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with DL-1 synthesis inhibitors. J. Pharm. Pharmacol. 48: 45-50
22. Rainsford, K. D., Ginsburg, I., Gadd, S. J. (1997) A comparison between the effects of meloxicam and other NSAIDs on the production of oxyradicals by human polymorphonuclear leucocytes. Inflammopharmacology 5: 9-19
23. Rashad, S., Revell, P., Hemingway, A., Low, F., Rainsford, K., Walker, F. (1989) Effects of non-steroidal anti-inflammatory drugs on the course osteoarthritis. Lancet ii: 519-522
24. Sato, T., Ito, A., Mon, Y. (1990) Interleukin-6 enhances the production of tissue inhibitor of metalloproteinases (TIMP but not that of matrix metalloproteinases by human fibroblasts. Biochem. Biophys. Res. Commun. 170: 824-829
25. Vane, J. R., Botting, R. M. (1995) New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44: 1-10
26. Weibkin, O. W., Muir, H. (1977) Synthesis of cartilage-specific proteoglycan by suspension cultures of adult chondrocytes. Biochem. J. 164: 269-272
27. Whicher, J. T., Westacott, C. I. (1992) The acute phase response. In: Whicher, J. T., Evans, S. W. (eds) Biochemistry of Inflammation. Kluwer Academic Publishers, Dordrecht, pp 243-269
28. Wiseman, E. H. (1985) Piroxicam and related oxicams. In: Rainsford, K. D. (ed.) Anti-inflammatory and Anti-rheumatic Drugs. Volume II, Newer Anti-inflammatory Drugs, CRC Press, Boca Raton, FL, pp 209-248